Near-Infrared Fluorescent Imaging of Cerebral Thrombi and Blood–Brain Barrier Disruption in a Mouse Model of Cerebral Venous Sinus Thrombosis

[1]  R. Weissleder,et al.  Molecular Imaging of Factor XIIIa Activity in Thrombosis Using a Novel, Near-Infrared Fluorescent Contrast Agent That Covalently Links to Thrombi , 2004, Circulation.

[2]  Ralph Weissleder,et al.  Seeing Within: Molecular Imaging of the Cardiovascular System , 2004, Circulation research.

[3]  J. Ferro,et al.  Prognosis of Cerebral Vein and Dural Sinus Thrombosis: Results of the International Study on Cerebral Vein and Dural Sinus Thrombosis (ISCVT) , 2004, Stroke.

[4]  O W Witte,et al.  Bedside assessment of cerebral perfusion reductions in patients with acute ischaemic stroke by near-infrared spectroscopy and indocyanine green. , 2004, Journal of neurology, neurosurgery, and psychiatry.

[5]  Ralph Weissleder,et al.  Novel Factor XIII Probes for Blood Coagulation Imaging , 2003, Chembiochem : a European journal of chemical biology.

[6]  U. Schmidt-Erfurth,et al.  Characterization of leakage activity in exudative chorioretinal disease with three-dimensional confocal angiography. , 2003, Ophthalmology.

[7]  D. Taggart,et al.  Preliminary experience with a novel intraoperative fluorescence imaging technique to evaluate the patency of bypass grafts in total arterial revascularization. , 2003, The Annals of thoracic surgery.

[8]  A. Villringer,et al.  Beyond the Visible—Imaging the Human Brain with Light , 2003, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[9]  R. Weissleder,et al.  In Vivo Imaging of Thrombin Activity in Experimental Thrombi With Thrombin-Sensitive Near-Infrared Molecular Probe , 2002, Arteriosclerosis, thrombosis, and vascular biology.

[10]  R. Weissleder,et al.  Fluorescence molecular tomography resolves protease activity in vivo , 2002, Nature Medicine.

[11]  J. Jarosz,et al.  Magnetic resonance imaging of cerebral venous sinus thrombosis. , 2002, Clinical radiology.

[12]  V. Fuster,et al.  Clinical Imaging of the High-Risk or Vulnerable Atherosclerotic Plaque , 2001, Circulation research.

[13]  M. Moskowitz,et al.  Structural and functional disruption of vascular smooth muscle cells in a transgenic mouse model of amyloid angiopathy. , 2001, The American journal of pathology.

[14]  G. Cosnard,et al.  Diffusion-weighted imaging patterns of brain damage associated with cerebral venous thrombosis. , 2001, AJNR. American journal of neuroradiology.

[15]  I. Bone,et al.  Cerebral venous thrombosis: anticoagulants or thrombolyic therapy? , 2000, Journal of neurology, neurosurgery, and psychiatry.

[16]  A. Houng,et al.  Catalytic Life of Activated Factor XIII in Thrombi: Implications for Fibrinolytic Resistance and Thrombus Aging , 2000, Circulation.

[17]  T. Desmettre,et al.  Fluorescence properties and metabolic features of indocyanine green (ICG) as related to angiography. , 2000, Survey of ophthalmology.

[18]  H. Allroggen,et al.  Cerebral venous sinus thrombosis , 2000, Postgraduate medical journal.

[19]  V. Yee,et al.  Blood coagulation factor XIII: structure and function. , 1999, Thrombosis research.

[20]  H. Urbach,et al.  Diffusion- and perfusion-weighted magnetic resonance imaging in deep cerebral venous thrombosis. , 1999, Stroke.

[21]  C. McDougall,et al.  Cerebral venous thrombosis: combined intrathrombus rtPA and intravenous heparin. , 1999, Stroke.

[22]  Lewis,et al.  Cerebral venous thrombosis: nothing, heparin, or local thrombolysis? , 1999, Stroke.

[23]  A. Kaufmann,et al.  Near-Infrared Spectroscopy Monitored Cerebral Venous Thrombolysis , 1999, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[24]  M. B. Lewis,et al.  Cerebral venous thrombosis: nothing, heparin, or local thrombolysis? , 1999, Stroke.

[25]  S Mordon,et al.  Indocyanine green: physicochemical factors affecting its fluorescence in vivo. , 1998, Microvascular research.

[26]  A. D. de Crespigny,et al.  Experimental Cerebral Venous Thrombosis: Evaluation Using Magnetic Resonance Imaging , 1996, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[27]  J. Slakter,et al.  Adverse Reactions due to Indocyanine Green , 1994 .

[28]  C. S. Davidson,et al.  Indocyanine green: observations on its physical properties, plasma decay, and hepatic extraction. , 1960, The Journal of clinical investigation.

[29]  E. Wood,et al.  A tricarbocyanine dye for continuous recording of dilution curves in whole blood independent of variations in blood oxygen saturation. , 1957, Proceedings of the staff meetings. Mayo Clinic.